Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease
- PMID: 2002499
- DOI: 10.1016/0022-2836(91)90881-6
Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease
Abstract
The deposition of amyloid beta A4 in the brain is a major pathological hallmark of Alzheimer's disease. Amyloid beta A4 is a peptide composed of 42 or 43 amino acid residues. In brain, it appears in the form of highly insoluble, filamentous aggregates. Using synthetic peptides corresponding to the natural beta A4 sequence as well as analog peptides, we demonstrate requirements for filament formation in vitro. We also determine aggregational properties and the secondary structure of beta A4. A comparison of amino-terminally truncated beta A4 peptides identifies a peptide spanning residues 10 to 43 as a prototype for amyloid beta A4. Infrared spectroscopy of beta A4 peptides in the solid state shows that their secondary structure consists of a beta-turn flanked by two strands of antiparallel beta-pleated sheet. Analog peptides containing a disulfide bridge were designed to stabilize different putative beta-turn positions. Limited proteolysis of these analogs allowed a localization of the central beta-turn at residues 26 to 29 of the entire sequence. Purified beta A4 peptides are soluble in water. Size-exclusion chromatography shows that they form dimers that, according to circular dichroism spectroscopy, adopt a beta-sheet conformation. Upon addition of salts, the bulk fraction of peptides precipitates and adopts a beta-sheet structure. Only a small fraction of peptides remains solubilized. They are monomeric and adopt a random coil conformation. This suggests that the formation of aggregates depends upon a hydrophobic effect that leads to intra- and intermolecular interactions between hydrophobic parts of the beta A4 sequence. This model is sustained by the properties of beta A4 analogs in which hydrophobic residues were substituted. These peptides show a markedly increased solubility in salt solutions and have lost the ability to form filaments. In contrast, the substitution of hydrophilic residues leads only to small deviations in the shape of filaments, indicating that hydrophilic residues contribute to the specificity of interactions between beta A4 peptides.
Similar articles
-
Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides.J Mol Biol. 1992 Nov 20;228(2):460-73. doi: 10.1016/0022-2836(92)90835-8. J Mol Biol. 1992. PMID: 1453457
-
Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.J Mol Biol. 1992 Jun 20;225(4):1075-93. doi: 10.1016/0022-2836(92)90106-t. J Mol Biol. 1992. PMID: 1613791
-
Human and rodent sequence analogs of Alzheimer's amyloid beta A4 share similar properties and can be solubilized in buffers of pH 7.4.Eur J Biochem. 1991 Oct 1;201(1):61-9. doi: 10.1111/j.1432-1033.1991.tb16256.x. Eur J Biochem. 1991. PMID: 1915378
-
Structural determinants of the Alzheimer's amyloid beta-peptide.J Neurochem. 1994 Oct;63(4):1191-8. doi: 10.1046/j.1471-4159.1994.63041191.x. J Neurochem. 1994. PMID: 7931272 Review.
-
A beta A4 amyloid precursor protein gene and Alzheimer's disease.Eur J Biochem. 1996 Apr 1;237(1):6-15. doi: 10.1111/j.1432-1033.1996.0006n.x. Eur J Biochem. 1996. PMID: 8620894 Review.
Cited by
-
Oil Palm Phenolics Inhibit the In Vitro Aggregation of β-Amyloid Peptide into Oligomeric Complexes.Int J Alzheimers Dis. 2018 Jan 31;2018:7608038. doi: 10.1155/2018/7608038. eCollection 2018. Int J Alzheimers Dis. 2018. PMID: 29666700 Free PMC article.
-
Apolipoprotein J and Alzheimer's amyloid beta solubility.Biochem J. 1996 Jun 1;316 ( Pt 2)(Pt 2):671-9. doi: 10.1042/bj3160671. Biochem J. 1996. PMID: 8687416 Free PMC article.
-
Factors affecting the physical stability (aggregation) of peptide therapeutics.Interface Focus. 2017 Dec 6;7(6):20170030. doi: 10.1098/rsfs.2017.0030. Epub 2017 Oct 20. Interface Focus. 2017. PMID: 29147559 Free PMC article. Review.
-
Mechanisms of amyloid beta protein-induced modification in ion transport systems: implications for neurodegenerative diseases.Cell Mol Neurobiol. 2001 Jun;21(3):173-213. doi: 10.1023/a:1010932603406. Cell Mol Neurobiol. 2001. PMID: 11569534 Free PMC article. Review.
-
Amyloids: The History of Toxicity and Functionality.Biology (Basel). 2021 May 1;10(5):394. doi: 10.3390/biology10050394. Biology (Basel). 2021. PMID: 34062910 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical